During the past decade, Plains Clinical Research Center, LLC conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 6 clinical trials were completed, i.e. on average, 54.5% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 5 clinical trials were completed. i.e. 83.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Plains Clinical Research Center, LLC" #1 sponsor was "Pfizer" with 4 trials, followed by "Allergan" with 2 trials sponsored, "Exact Sciences Corporation" with 2 trials sponsored, "Mutual Pharmaceutical Company, Inc." with 2 trials sponsored and "Checkable Medical Inc" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Plains Clinical Research Center, LLC" #1 collaborator was "Curebase Inc." with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Premier Research Group plc" with 1 trials as a collaborator and "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Plains Clinical Research Center, LLC" are "Colorectal Cancer" (3 trials), "Healthy" (2 trials), "Migraine, With or Without Aura" (2 trials), "Osteoarthritis, Hip" (2 trials) and "Osteoarthritis, Knee" (2 trials). Many other conditions were trialed in "Plains Clinical Research Center, LLC" in a lesser frequency.

Most popular intervention types in "Plains Clinical Research Center, LLC" are "Drug" (6 trials), "Biological" (5 trials), "Other" (3 trials), "Diagnostic Test" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Placebo-matching Ubrogepant" (2 trials), "Tanezumab 2.5 mg" (2 trials), "Ubrogepant" (2 trials) and "Blood Sample Collection" (1 trials). Other intervention names were less common.

The vast majority of trials in "Plains Clinical Research Center, LLC" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Plains Clinical Research Center, LLC". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Plains Clinical Research Center, LLC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Plains Clinical Research Center, LLC, 2 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".